Neuburgh Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $11.6M | Buy |
68,176
+20,912
| +44% | +$3.54M | 0.36% | 59 |
|
|
2019
Q2 | $8.67M | Sell |
47,264
-4,144
| -8% | -$760K | 0.28% | 77 |
|
|
2019
Q1 | $9.46M | Buy |
51,408
+976
| +2% | +$180K | 0.32% | 70 |
|
|
2018
Q4 | $8.36M | Sell |
50,432
-2,112
| -4% | -$350K | 0.33% | 68 |
|
|
2018
Q3 | $10.1M | Sell |
52,544
-3,184
| -6% | -$614K | 0.33% | 67 |
|
|
2018
Q2 | $9.47M | Sell |
55,728
-496
| -0.9% | -$84.3K | 0.32% | 69 |
|
|
2018
Q1 | $9.16M | Buy |
56,224
+25,680
| +84% | +$4.19M | 0.32% | 67 |
|
|
2017
Q4 | $4.58M | Sell |
30,544
-848
| -3% | -$127K | 0.16% | 115 |
|
|
2017
Q3 | $4.77M | Sell |
31,392
-10,992
| -26% | -$1.67M | 0.18% | 111 |
|
|
2017
Q2 | $5.46M | Sell |
42,384
-1,760
| -4% | -$227K | 0.21% | 97 |
|
|
2017
Q1 | $4.83M | Sell |
44,144
-4,368
| -9% | -$478K | 0.19% | 104 |
|
|
2016
Q4 | $3.57M | Buy |
+48,512
| New | +$3.57M | 0.16% | 112 |
|